Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy.

MLA

Kim, Ji Woong, et al. “Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy.” Cells, vol. 10, no. 3, Mar. 2021. EBSCOhost, https://doi.org/10.3390/cells10030670.

APA

Kim, J. W., Cho, Y. B., & Lee, S. (2021). Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy. Cells, 10(3). https://doi.org/10.3390/cells10030670

Chicago

Kim, Ji Woong, Yea Bin Cho, and Sukmook Lee. 2021. “Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy.” Cells 10 (3). doi:10.3390/cells10030670.